Introduction
Extensive epidemiologic studies have investigated the relationship between meat consumption and CRC risk. Meat consumption was shown not to be associated with CRC in a large meta-analysis of 34 case-control and 14 cohort studies published during 1973-1999, while red meat and processed meat intake were associated with moderate increases in CRC risk (1) . A large cohort study has recently confirmed an increased risk of developing CRC associated with consumption of red meat and processed meats, and demonstrated a protective effect for fish and poultry (2) . While many epidemiologic studies have assessed the risk of meat consumption on developing CRC(1;3), there is a paucity of data addressing the risk of meat consumption on outcomes in CRC patients.
Meat consumption is the major source of dietary arginine in humans -with high quantities of arginine found not only in red meat but also in pork, fish, and chicken(4).
Meat and meat products accounted for 37-38% of total daily arginine in two European studies, where subjects were estimated to have similar daily arginine intake to U.S. men (i.e. 4.2 -5.0 g/day)(5;6). In cell culture, normal cells become quiescent in an argininedeficient diet, whereas most transformed or malignant cells die (7;8) . Arginine supplementation (8) , particularly L-arginine (9) , has been shown to increase tumor growth in rodents whereas D-arginine may have tumor-inhibitory properties (9) . In human breast cancer tissue, dietary arginine has been shown to stimulate tumor growth (10) .
Importantly, arginine is the key substrate for two competing metabolic pathways believed to be involved in carcinogenesis: the nitric oxide (NO) synthase pathway and polyamine synthesis. Arginine is catabolized by NO synthase 2 (NOS2) and other NO synthases to form nitric oxide. Inducible isoforms of NOS2 are abundant in human colorectal adenomas (11) . NOS2 is also overexpressed in rat colon carcinoma tissues after azoxymethane treatment (12;13) , an effect that is inhibited by aspirin (12) . Apc Thus it has been suggested that NOS2-selective inhibitors may have a future role in CRC chemoprevention.
Arginine is catabolized by the enzyme arginase to form ornithine, the substrate for putrescine synthesis. This is the first step in polyamine biosynthesis and is catalyzed by the enzyme ornithine decarboxylase (ODC) (16) . Multiple abnormalities in the control of polyamine contents results in increased polyamine levels that can promote tumorigenesis (17) . APC, a gene that is mutated in FAP and in the majority of sporadic colon cancers, regulates ODC and therefore polyamine synthesis (18) . In accordance,
Loss of APC increases ODC expression, polyamine content, and small intestinal tumor formation (19) . Treatment with the chemopreventive agent α-difluoromethylornithine (DFMO), a suicide inhibitor of ODC, has been shown to decrease polyamine levels and suppress tumorigenesis in the small intestine and colon of Apc Min/+ mice (an FAP mouse model) (19) , and decrease colorectal tissue polyamine levels in human patients with colon polyps (20) .
Together, DFMO and non-steroidal anti-inflammatory drugs (NSAIDs) inhibit intestinal cancer development in mouse models (21) . Sulindac (22) and aspirin (23) are
NSAIDs that have been demonstrated to activate the polyamine catabolic pathway via increased expression of spermine spermidine acetyltranferase (SSAT), polyamine acetylation and subsequent export. It is not known whether this mechanism exists for the selective cyclooxygenase-2 (COX-2) inhibitors.
In the experimental portion of this investigation, we examine the role of Nos2 and dietary arginine in murine carcinogenesis via gene knockout mouse model systems. We also investigate the effects of celecoxib on Odc and Ssat, and test whether celecoxib treatment can inhibit intestinal tumorigenesis in FAP mouse models. In the epidemiologic portion of this study, we investigate the effects of dietary meat 7 consumption on tumor characteristics at presentation and survival in CRC cases. We hypothesized that any differential effects of meat consumption on these clinical outcomes might be mediated through gene-environment interactions, and thus manifest predominantly in cases with multifactorial inherited susceptibility to CRC (i.e. familial CRC cases).
Materials & Methods

Mouse experimental procedures.
Animals and experimental conditions: C57BL/6J-Apc Min mice were acquired at 6 weeks of age from the Jackson Laboratory (Bar Harbor, ME) and bred in Offspring were genotyped using allele-specific polymerase chain reaction (PCR) as described in genotyping protocols from the Jackson Labs website (http://jaxmice.jax.org/). All animals were raised in cages under non-sterile microisolator conditions and were put on the various treatments at age 5-6 weeks. Animals were fed with an AIN-93G diet (Harlan Teklad), a defined diet which includes 1.08 grams arginine/kg mouse body weight per day. Mice were sacrificed at age of 110 days by CO 2 inhalation and were analyzed by tumor scoring, tumor grade evolution, and Northern blotting. Throughout the experiment, animals had access to drinking water and food ad libitum. Mice have a 7.5 times larger metabolic rate compared to humans (24) . Therefore, mouse dietary arginine concentrations (1.08 -1.38 grams arginine/kg mouse body weight per day, as described previously (15)) were adjusted for differences in metabolic rates, i.e. concentrations in the upper range of that consumed by human (121 mg/kg per day, as described (6)). After termination, whole small intestine and colon segments were removed, flushed with buffered saline, opened longitudinally and spread out with the mucosal surface up. A Swiss gut roll of small intestine, colon, and all grossly evident colon tumors were fixed in 10% buffered formalin. Processed, paraffin-embedded 5-micron sections were stained with hematoxylin and eosin prior to evaluation by a veterinary pathologist. The grade of dysplasia for each adenoma examined histologically was determined on the basis of criteria outlined previously (25) . The 1 cm tumor-free portions of the ileum were placed in TRIzol ® reagent (Gibco, BLR) homogenized using a Polytron homogenizer, and processed for the isolation of total cellular RNA [46] . Twenty μg of total RNA was separated on a 1%
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agarose/formaldehyde gel and transferred to a nylon membrane (Hybon-N, Amersham).
The cDNA probes for Northern blotting were prepared using [ 
Combined effects of DFMO and celecoxib on tumorigenesis in Apc
Min/+ mice. To assess the combined effect of celecoxib and DFMO on intestinal tumorigenesis, DFMO was administered alone, or in combination with celecoxib (500 ppm in the diet) at two different doses of 0.5% and 2% in the drinking water. The independent effects of celecoxib (500 ppm in the diet) on intestinal tumorigenesis were also tested. After termination, whole small intestine and colon segments were removed, flushed with buffered saline, opened longitudinally and spread out with the mucosal surface up.
Tissues were fixed in 10% neutral buffered formalin for 24 hours and then placed in 70%
ethanol. Tumor number per mouse was evaluated using a LSGA epi-illuminator dissecting microscope (Olympus Optical Co., Ltd, Tokyo, Japan) at 20x magnification.
Tumors larger than 0.5 millimeter were counted and their diameter was measured. All assessments were done by the same observer who was blinded to the mouse treatment group. Animal weight at the time of sacrifice was recorded to determine if they absorbed similar amounts of food and water after the aforementioned treatments.
Epidemiologic CRC gene-environment study.
Study population: For the present study, all incident colorectal cancer cases diagnosed between 1994 and 1996 were obtained from a previously described study investigating gene-environment interactions in colorectal cancer (27) . Family history of cancer was ascertained via telephone interview. Familial (non-HNPCC non-FAP) CRC cases were identified as those having at least one first degree relative with CRC. Amsterdam criteria were used to define HNPCC families (28) . HNPCC and FAP cases, familial cases, and sporadic CRC cases were identified using available family history data. 1256 cases were consented for the study during the defined period, including 1007 sporadic CRC cases, 228 familial CRC cases, and 21 HNPCC cases, as described elsewhere (29) . All HNPCC cases were subsequently excluded from the analysis. 511 of the sporadic and familial CRC cases completed a food frequency questionnaire (FFQ).
Clinical and demographic data:
Clinical and demographic data from consented cases were obtained from the Cancer Surveillance Programs of Orange County, Imperial
County, and San Diego County, California (CSPOC/SANDIOCC databases) (27) .
Recorded data included demographic information (age, gender, ethnicity), histology, Meat and other food consumption: Food consumption was self-reported via a validated 100-item NCI-Block food-frequency questionnaire (FFQ), where patients were asked to report their usual eating habits during the one year prior to diagnosis of CRC(32;33).
Micronutrient data (i.e., calcium, iron), total daily fiber intake, total daily energy intake and body mass index (BMI) were calculated from the self-reported FFQ responses. The number of medium-sized servings consumed per week for each meat item was calculated by multiplying the number of servings consumed per week by the estimated serving size (i.e. 0.5 for small, 1.0 for medium, and 1.5 for large). Meat consumption quartiles were subsequently calculated. Cases in the highest quartile of meat consumption (Q4) were compared to those in all of the other meat consumption quartiles (Q1-Q3). Arginine intake for each FFQ food item was calculated by estimating the quantity of arginine per serving from widely available computer-based food composition tables(4), and multiplying this value by the consumption frequency and serving size for each food item. As an internal control measure, manual chart review was conducted on all cases reporting total daily energy intake of less than 500 kcal (n = 15) or greater than 5000 kcal (n = 6), to ensure valid FFQ reporting, including one patient reporting extremely high meat intake (61.5 medium-size serving equivalents per week). All such cases were determined to contain complete and valid data, and were included in the analysis. 
Statistical analysis.
Results
Mouse experimental studies -the role of arginine and its catabolic product, polyamines, in intestinal tumorigenesis
Supplemental dietary arginine effect on incidence of high-grade adenomas in
We examined the effect of dietary arginine on colonic tumor incidence in mice.
Apc
Min/+ Nos2 +/+ mice or Apc Min/+ Nos2 knockout mice were fed an AIN-93G diet supplemented with dietary arginine in the drinking water (0, 0.02% and 0.2%).
Supplementing the diet with arginine did not affect animal weight. All mice weighed 20-23 grams, i.e. they absorbed similar amounts of food and water in the different treatment groups. Apc Min/+ mice expressing Nos2 showed an arginine-dependent increase in highgrade adenoma incidence in the colon (Fig. 1) . Supplementing the diet with 0.2% arginine resulted in a more than 2-fold increase in tumor incidence (P = 0.042). In contrast, low-grade adenoma incidence in mice expressing Nos2 was not affected by dietary arginine. In Nos2 knockout mice, adenoma incidence was not affected by arginine; therefore, the increase in colon tumor grade with dietary arginine was Nos2-dependent.
Celecoxib effect on polyamine metabolic enzymes in intestinal tissue of Apc
Min/+ mice.
We tested whether celecoxib affects polyamine metabolism in the intestinal tract of Min mice. After 60 days of treatment, celecoxib suppresses the steady state RNA levels of Odc, and induces steady state RNA levels of Ssat in a dose dependent manner ( Figs. 2A and 2B). Celecoxib effects on Odc and Ssat expression were observed in the small intestine but not in the colon, and had statistically significant values for Odc at both 150 and 500 ppm, concentrations (P < 0.001) and for Ssat at the concentration of 500 ppm (P = 0.002). We found a statistically significant decrease in the concentration of putrescine, the product of ODC activity, in the small intestine of mice treated with 500 ppm of celecoxib (P = 0.04) ( Table I) . We found also a marginal decrease in tissue levels of N1-acetylspermidine (the product of the SSAT enzyme activity, P = 0.07). This decrease was small and not statistically significant possibly due to luminal secretion of acetylated spermidine.
Combination of DFMO and celecoxib: effect on tumorigenesis in Apc
DFMO at a concentration of 0.5% did not affect tumor number in Apc Min/+ mice fed with a defined AIN93G diet (Fig. 2C) . A higher dose of DFMO (2%) reduced the tumor number per mouse by about 50%. We did not observe a significant tumor location dependency with the DFMO treatment (data not shown). Celecoxib (500 ppm) reduced tumor number by about 50% with little location dependency (P = 0.0003). The combination of 0.5% DFMO and 500 ppm of celecoxib reduced tumor number by over 80% (P < 0.0001) and was more effective in suppressing distal intestinal tumor number, compared to proximal intestinal tumor number (data not shown). The combination of a higher dose of DFMO with celecoxib did not improve the efficacy of these agents to suppress tumorigenesis (P < 0.0001). We found a statistically significant increase in body weights of mice treated with celecoxib (P = 0.02, data not shown). Mice treated with 2% DFMO alone or in combination with celecoxib had a statistically significant decrease in body weights compared with control animals (P = 0.005 and P = 0.04, respectively). No effect on body weight was found in mice treated with 0.5% DFMO in combination with celecoxib implying that the water consumption and the caloric intake of the treatment mice was similar to these of the control mice.
Epidemiologic Studies -effect of meat and arginine intake on clinical outcomes CRC study population.
The 511 incident CRC cases identified included 367 sporadic CRC cases and 144 familial CRC cases. Demographic comparisons for these groups (Table II) Table IV , for familial and sporadic CRC patients.
Relationship between meat consumption and total daily arginine intake
The relationship between meat consumption and total daily arginine intake was investigated analytically. For the overall group (n=511), mean arginine intake from all foods was estimated at 23.2 grams/week (i.e. 3.3 grams/day). The median meat-derived arginine intake was estimated at 11.7 grams/week (1.7 grams/day). Forty-nine percent of total daily arginine intake in this study was due to meat consumption. Meat consumption was revealed to be a predictor of total daily arginine intake in linear regression analysis (R-square = 0.77, P<0.0001) (Fig. 3) .
Effects of meat intake on clinical outcomes.
For familial cases, no differences in tumor grade (P = 0.32), or stage at presentation (P = 0.48) were observed based on meat consumption quartile. Similarly, among sporadic CRC cases, no differences in tumor grade (P = 0.75), or stage at presentation (P = 0.18)
were noted based on meat consumption quartile (Table IV) . Among familial CRC cases, overall survival (OS) was significantly decreased for cases in the highest meat consumption quartile (n = 36) vs. cases in all other meat consumption quartiles (n = 108) (quartile 4: 10-year OS = 42%; Q1-Q3: 10-year OS = 65%; P = 0.017) (Fig. 4) . No statistically significant differences in OS were detected for cases in meat consumption quartiles Q1-Q3 (P = 0.34). Subset analysis revealed that among the 101 colon cancer cases, borderline significant decreased OS was observed for cases in the highest meat consumption quartile (n = 74) vs. cases in all other meat consumption quartiles (n = 27) (Q4: 10-year OS = 44%; Q1-Q3: 10-year OS = 70%; P = 0.052). No statistically significant differences were noted for the 43 familial rectal cancer cases based on meat consumption group (Q4: 10-year OS = 33%; Q1-Q3: 10-year OS = 60%; P = 0.19), however these subset analyses were underpowered as there were only 9 rectal cancer patients in meat consumption Q4. Among sporadic CRC cases, OS was similar for cases in the highest meat consumption quartile (n = 91) compared to cases in all other meat consumption quartiles (n = 276) (Q4: 10-year OS = 62%; Q1-Q3: 10-year OS = 62%; P = 0.89.
Variables known to predict survival in CRC were included into the multivariate survival model, including age, gender, and stage at presentation. The following variables were highly correlated with meat consumption quartile but were not significantly associated with survival: daily fiber intake, daily calcium intake, daily iron intake, and total daily energy intake -thus they were not included in the final multivariate analysis. For familial CRC cases, the highest meat consumption quartile was associated with an increased hazard ratio (HR) of 2.24, 95% C.I. 1.25-4.03, (P = 0.007) compared to familial CRC cases in all other meat consumption quartiles after adjustment for age, gender, and stage at presentation (Table V) . The trend test for meat consumption quartile among familial CRC cases was not statistically significant (HR = 1.08, 95% CI 0.84-1.39; P = 0.57). For sporadic CRC cases, no statistically significant increased hazard was noted for the highest quartile of meat consumption group (HR = 1.01, 95%
CI 0.67-1.51; P = 0.98) compared to sporadic CRC cases in all other meat consumption quartiles after adjustment for age, gender, and stage at presentation (Table V) .
Discussion
The results presented in this study demonstrate that meat and its major component, Arginine supplementation increased high grade intestinal tumor incidence in
Apc
Min/+ Nos2 +/+ mice, but not in Nos2 knockout mice. Thus, Nos2 is involved in the arginine-dependent increase in colon adenoma grade. In accordance, a separate study from our laboratory described dietary arginine-induced increases in overall colon tumor incidence and number that were Nos2-dependent (15) . In that study, dietary arginine was found to primarily affect colonic tumor initiation in Apc Min/+ mice. Similarly, our present findings suggest that supplemental arginine-induced tumorigenesis is mediated through NO synthase. Assessment of polymorphisms in the NOS genes and promoters could potentially help explain our epidemiologic findings, which implicate geneenvironment interactions between meat intake and improved survival for familial CRC cases but not sporadic CRC cases. Currently, Nos2 single nucleotide gene polymorphisms with functional promoter activity have been described (34-36), but have not been reported in CRC patients.
As shown in Table III , fish, poultry, and pork contain comparable amounts of arginine to red meat. We have demonstrated in this study that meat consumption represents a reasonable estimator of total arginine intake (Fig. 3) . Others have shown that arginine estimates from nutrient composition tables and short-term food intake records correlate with serum arginine levels (6) . Even so, the poor outcomes associated with the highest quartile of meat consumption noted in our study may reflect the effects meat constituents other than arginine, or different cooking methods that could not be accounted for in this analysis. Heterocyclic amines (HCAs) formed in meat during cooking(37-40), polycyclic aromatic hydrocarbons (PAHs)(41), and N-nitroso compounds (NOCs, i.e. from processed meat)(42) are known carcinogens that have been implicated in colorectal carcinogenesis, and could account for the observed survival effects of the present study. Red meat intake, and also intake of heme iron has been associated with high NOC levels, thus implicating a role for iron in carcinogenesis(43). The FFQ utilized in our study is not adequately designed to assess cooking methods or level of doneness, thus we were unable to assess the effects of HCAs, PAHs, or NOCs. However a FFQ model has recently been developed by others to assess intake of these carcinogenic compounds, and future outcomes-based studies using this type of model may reveal the effect of these compounds on survival in CRC (44) . Table Legends   Table I . Polyamine content in the small intestine of Apc Min/+ mice treated with 500 ppm celecoxib. *, P = 0.04 indicates statistically significant difference vs. control group. 
